Market Overview:
The global drugs for warts market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of warts, rising awareness about available treatment options, and growing demand for minimally invasive procedures. Salicylic acid is the most commonly used drug for wart treatment and accounts for a major share of the global drugs for warts market. It is followed by bleomycin and DNCB. Imiquimod accounted for a small share of the overall market in 2017 but is expected to grow at a high rate during the forecast period owing to its high efficacy in treating genital warts. Based on application, the global drugs for wart market is segmented into common wart, flat wart,, genital wart,, plantar wart,, and others (molluscum contagiosum).
Product Definition:
Drugs for warts are a type of medication used to treat warts on the skin. Warts are caused by viruses and can be treated with over-the-counter drugs or prescription medications.
Salicylic Acid:
Salicylic acid is a phenol derivative and an important intermediate in the production of chemicals, such as salicylic acid esters. Salicylic acid is also used in pharmaceutical drugs for the treatment of warts. The growth factor for salicylic acid includes its usage in drug manufacturing and research activities by various companies over the world.
Bleomycin:
Bleomycin is an antibiotic used for the treatment of blemishes, warts, and skin tags. It works by killing the bacteria that causes the infection. The drug has a wide range of applications including oncology indications such as cervical cancer, bladder cancer; infectious diseases such as tuberculosis; and endobiotic infections.
Application Insights:
The common wart held the largest revenue share of over 40.0% in 2017. The segment is expected to expand at a steady CAGR during the forecast period owing to its high prevalence and easy availability, especially in countries such as U.K., Germany, China, India and Australia. Flat warts also had significant market share in 2017 due to their low prevalence rate and easy treatment method which does not require any hospitalization or surgery thus making it easily available for commoners with less financial capability.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for modern treatment options are some of the factors responsible for its large share. Moreover, increasing prevalence of human papillomavirus (HPV) is one of the major factors driving growth in this region.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income leading to increased demand for drugs for warts treatment among patients from emerging economies such as India & China & Malaysia etc., especially due to growing awareness about available treatments and their benefits as comparedto homeopathy or traditional herbal medicines used traditionally by local communities.
Growth Factors:
- Increasing incidence of warts
- Growing awareness about the available treatment options for warts
- Rising demand for over-the-counter drugs for wart treatment
- Technological advancements in wart treatment methods 5. Availability of generic versions of branded drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Drugs for Warts Market Research Report
By Type
Salicylic Acid, Bleomycin, Dinitrochlorobenzene, Cidofovir, Imiquimod, Cantharidin
By Application
Common Wart, Flat Wart, Genital Wart, Plantar Wart, Others
By Companies
Merck, Dr. Scholl’s, DuoFilm, Rite Aid, Medigene, Hemispherx Biopharma, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Drugs for Warts Market Report Segments:
The global Drugs for Warts market is segmented on the basis of:
Types
Salicylic Acid, Bleomycin, Dinitrochlorobenzene, Cidofovir, Imiquimod, Cantharidin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Common Wart, Flat Wart, Genital Wart, Plantar Wart, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Dr. Scholl’s
- DuoFilm
- Rite Aid
- Medigene
- Hemispherx Biopharma
- Merck
Highlights of The Drugs for Warts Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Salicylic Acid
- Bleomycin
- Dinitrochlorobenzene
- Cidofovir
- Imiquimod
- Cantharidin
- By Application:
- Common Wart
- Flat Wart
- Genital Wart
- Plantar Wart
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drugs for Warts Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drugs for warts are medications that are used to treat the symptoms of warts, such as pain, itching, and swelling. Drugs for warts may also be used to prevent the development of new wart lesions.
Some of the key players operating in the drugs for warts market are Merck, Dr. Scholl’s, DuoFilm, Rite Aid, Medigene, Hemispherx Biopharma, Merck.
The drugs for warts market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drugs for Warts Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drugs for Warts Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drugs for Warts Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drugs for Warts Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drugs for Warts Market Size & Forecast, 2020-2028
4.5.1 Drugs for Warts Market Size and Y-o-Y Growth
4.5.2 Drugs for Warts Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Salicylic Acid
5.2.2 Bleomycin
5.2.3 Dinitrochlorobenzene
5.2.4 Cidofovir
5.2.5 Imiquimod
5.2.6 Cantharidin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Common Wart
6.2.2 Flat Wart
6.2.3 Genital Wart
6.2.4 Plantar Wart
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drugs for Warts Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drugs for Warts Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Salicylic Acid
9.6.2 Bleomycin
9.6.3 Dinitrochlorobenzene
9.6.4 Cidofovir
9.6.5 Imiquimod
9.6.6 Cantharidin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Common Wart
9.10.2 Flat Wart
9.10.3 Genital Wart
9.10.4 Plantar Wart
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Salicylic Acid
10.6.2 Bleomycin
10.6.3 Dinitrochlorobenzene
10.6.4 Cidofovir
10.6.5 Imiquimod
10.6.6 Cantharidin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Common Wart
10.10.2 Flat Wart
10.10.3 Genital Wart
10.10.4 Plantar Wart
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Salicylic Acid
11.6.2 Bleomycin
11.6.3 Dinitrochlorobenzene
11.6.4 Cidofovir
11.6.5 Imiquimod
11.6.6 Cantharidin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Common Wart
11.10.2 Flat Wart
11.10.3 Genital Wart
11.10.4 Plantar Wart
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Salicylic Acid
12.6.2 Bleomycin
12.6.3 Dinitrochlorobenzene
12.6.4 Cidofovir
12.6.5 Imiquimod
12.6.6 Cantharidin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Common Wart
12.10.2 Flat Wart
12.10.3 Genital Wart
12.10.4 Plantar Wart
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Salicylic Acid
13.6.2 Bleomycin
13.6.3 Dinitrochlorobenzene
13.6.4 Cidofovir
13.6.5 Imiquimod
13.6.6 Cantharidin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Common Wart
13.10.2 Flat Wart
13.10.3 Genital Wart
13.10.4 Plantar Wart
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drugs for Warts Market: Competitive Dashboard
14.2 Global Drugs for Warts Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Dr. Scholl’s
14.3.3 DuoFilm
14.3.4 Rite Aid
14.3.5 Medigene
14.3.6 Hemispherx Biopharma
14.3.7 Merck
